Multiple sclerosis and neuropsychiatric disorders during the COVID-19 pandemic. Literature review
Since the spread of COVID-19 infection worldwide in December 2019, quarantine has been initiated to stop human contact and thus limit the spread of the disease. However, a decrease in human contact and visits to doctors has led to another problem in patients with chronic diseases, especially those...
Saved in:
Main Authors: | K. Brasas, V. Lileikytė, D. Mickevičienė |
---|---|
Format: | Article |
Language: | English |
Published: |
Vilnius University Press
2022-03-01
|
Series: | Neurologijos seminarai |
Subjects: | |
Online Access: | https://www.journals.vu.lt/neurologijos_seminarai/article/view/29287 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Willingness and Hesitancy to Vaccinate Against COVID-19 in People with Multiple Sclerosis
by: D. Bučaitė, et al.
Published: (2023-11-01) -
Treatment of Multiple Sclerosis with Cladribine Tablets: Literature Review and the Guidance of the Lithuanian Association of Neurologists
by: R. Kizlaitienė, et al.
Published: (2024-03-01) -
Recommendations for the treatment of multiple sclerosis with disease-modifying drugs during the COVID-19 pandemic
by: R. Kizlaitienė, et al.
Published: (2020-06-01) -
Adherence to disease modifying therapies in patients with multiple sclerosis
by: D. Pileckė, et al.
Published: (2019-06-01) -
From pathogenesis to new developments in treatment of primary progressive multiple sclerosis. Literature review
by: A. Juknelytė, et al.
Published: (2020-03-01)